港股異動丨美東汽車(01268.HK)低開近6% 擬折價6%至9.9%配售8100萬股股份
格隆匯6月3日丨美東汽車(01268.HK)低開近6%,報16.54港元,總市值192億港元。據銷售文件顯示,美東汽車(01268.HK)擬按每股15.84港元至16.52港元,以先舊後新方式配售6117萬股,最多集資10.11億港元。配股價較昨日該股收市價17.58港元有6%至9.9%折讓。交易後該公司設有90天禁售期,所得款項用於潛在收購及一般用途。高盛為安排行之一。該公司擬把配股所得資金,用於伺機併購和一般企業用途。美東汽車股價昨上揚3.4%,年初至今已逆市累漲逾72%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.